Pruritus and paresthesia after i.v. administration of Gd-DTPA.
作者信息
Chan K, Bosanko C M, Wang A M
机构信息
William Beaumont Hospital, Royal Oak, MI 48072.
出版信息
AJNR Am J Neuroradiol. 1989 Sep-Oct;10(5 Suppl):S53.
Abstract
摘要
相似文献
1
Pruritus and paresthesia after i.v. administration of Gd-DTPA.
AJNR Am J Neuroradiol. 1989 Sep-Oct;10(5 Suppl):S53.
2
Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
Invest Radiol. 1991 Nov;26 Suppl 1:S221-3; discussion S232-5. doi: 10.1097/00004424-199111001-00075.
3
[Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Med Clin (Barc). 1996 Feb 10;106(5):197.
4
Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
AJNR Am J Neuroradiol. 1997 Apr;18(4):785-6; author reply 786-8.
5
Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
AJNR Am J Neuroradiol. 1990 Nov-Dec;11(6):1167; discussion 1168-9.
6
[Artificial contrasting during magnetic resonance tomography].
Vestn Rentgenol Radiol. 1997 Jan-Feb(1):45-52.
7
[Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
Rofo. 1988 Jun;148(6):683-9. doi: 10.1055/s-2008-1048272.
8
Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
AJNR Am J Neuroradiol. 1994 Mar;15(3):523-4.
9
Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.
Lancet. 1992 Nov 7;340(8828):1168. doi: 10.1016/0140-6736(92)93203-y.
10
[Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA].
Rofo. 1994 Mar;160(3):218-21. doi: 10.1055/s-2008-1032410.
Zotero 插件